Category

Clinical Trials

Peter-Zerhouni-InDex-Pharmaceuticals

In-depth analysis of InDex Pharmaceuticals’ CONDUCT study

February 20, 2020

InDex Pharmaceuticals has announced the …

Scandinavian Biopharma secures 10.6 million EUR

February 20, 2020

Scandinavian Biopharma has been awarded …

MRI

First patient enrolled in Ascelia’s Phase III study

February 20, 2020

Ascelia Pharma has announced that …

Francesco Gatto

First patient enrolled in Elypta trial

February 11, 2020

Elypta has enrolled the first …

Alex Karlsson Parra

Immunicum presents updated data from Phase II trial

February 7, 2020

Immunicum has announced updated results …

FDA approved

Follicum’s Phase II study approved by the German Medicines Agency

January 30, 2020

Follicum has received approval from …

Encouraging data from Targovax

January 28, 2020

Targovax has announced the first …

AstraZeneca’s Phase II DESTINY-Gastric01 trial met primary endpoint

January 27, 2020

The AstraZeneca trial met primary …

AstraZeneca Research and Development

AstraZeneca’s Brilinta met primary endpoint

January 27, 2020

Brilinta reduced the risk of …

Washington

A Nordic precision medicine goldmine

Chris Tachibana

January 25, 2020

The combined Nordic population is …

Medivir phase II study published in Annals of Internal Medicine

January 22, 2020

Medivir has announced that the …

Update on Moberg Pharma Trial

January 22, 2020

Moberg Pharma has completed the …

AstraZeneca closes its Phase III STRENGTH trial for Epanova

January 14, 2020

Following the recommendation from an …

erik-kinneman

Neurovive completes recruitment in Phase 1a/b study

January 13, 2020

NeuroVive Pharmaceutical has announced the …

Immunovia achieves major milestone

January 8, 2020

Immunovia has announced that the …

Richard Godfrey

BerGenBio presents preliminary clinical data

January 7, 2020

BerGenBio has provided an update …

1
2
3
···
27